Voglivance GM 1mg/500mg/0.2mg Tablet
Marketer
OAK Vance Life Sciences Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglivance GM 1mg/500mg/0.2mg Tablet
Diabetic patients using the anti-diabetic combination drug, Voglivance GM (1mg/500mg/0.2mg), must adhere to their prescribed dosage regimen. This medication, administered orally with food, helps manage type 2 diabetes in adults by regulating blood glucose. Consistent daily intake at the same time maximizes efficacy. Dosage adjustments may be necessary based on individual blood sugar levels and response, as determined by your physician. Discontinuing this medication without medical supervision is strongly discouraged; abrupt cessation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Successful diabetes management integrates Voglivance GM with a balanced diet, regular physical activity, and weight management, as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a frequent side effect, manifested by symptoms such as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects encompass altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to evaluate blood cell counts and liver function, are crucial during treatment.
Primary Ingredients of Voglivance GM 1mg/500mg/0.2mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Voglivance GM 1mg/500mg/0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Voglivance GM 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglivance GM 1mg/500mg/0.2mg Tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Voglivance GM 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglivance GM 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglivance GM 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglivance GM 1mg/500mg/0.2mg Tablet works:
Each Voglivance GM tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglivance GM 1mg/500mg/0.2mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Voglivance GM 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Voglivance GM 1mg/500mg/0.2mg tablets are likely incompatible. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Voglivance GM 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice from a physician is recommended. The use of Voglivance GM 1mg/500mg/0.2mg Tablets is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Individuals with liver impairment should use Voglivance GM 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Voglivance GM 1mg/500mg/0.2mg Tablet :
Should you forget a Voglivance GM 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglivance GM 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently